Écrit par OMS | 28 Novembre 2017

Geneva, 28 November 2017: An estimated 1 in 10 medical products circulating in low- and middle-income countries is either substandard or falsified, according to new research from the World Health Organization (WHO).

This means that people are taking medicines that fail to treat or prevent disease. Not only is this a waste of money for individuals and health systems that purchase these...

Écrit par WILEY | 28 Novembre 2017

New research provides insights on the potential effects of weight on the health of individuals with rheumatoid arthritis (RA). A study published in Arthritis Care & Research examines how overweight and obesity may affect the likelihood of achieving remission in early RA. A separate study in Arthritis & Rheumatology focuses on weight change in early RA and patients’ subsequent risk of early...

Écrit par GlobalData | 24 Novembre 2017

Age-related macular degeneration (AMD) in the seven major markets of the US, France, Germany, Italy, Spain, UK, and Japan, saw the majority of diagnosed incident cases occurring in women (65.76%), with just over 7.40 million cases, while men accounted for 34.24%, with just under 3.85 million cases in 2016, according to GlobalData, a leading data and analytics company.

AMD is the most...

Écrit par Health Factory | 24 Novembre 2017

Le lauréat national du 1er Défi Santé Numérique dévoilé

Dans le cadre du Plan d’Investissements d’Avenir, Health Factory et le Pôle de compétitivité Alsace BioValley ont été choisis en février dernier pour organiser à l’échelon national les Défis Santé Numérique. PICCADOM, projet porté par un consortium de 4 entreprises, est lauréat du 1er Défi lancé par le...